|
OMEPRAZOLE SODIUM | ||
PRODUCT IDENTIFICATION |
||
CAS NO. | 73590-58-6,
(Base) 95510-70-6 (Sodium) |
|
EINECS NO. | ||
FORMULA | C17H18N3O3S·Na | |
MOL WT. | 366.82 | |
H.S. CODE |
||
TOXICITY |
||
SYNONYMS | Losev; Omeprazole; Prilosec; | |
(R,S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl) methyl]sulfinyl]- 1H-benzimidazole monosodium salt; Losec Sodium; Omepral; Andra; Sodium 5-methoxy-2-[(4-methoxy-3,5- dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole; |
||
SMILES |
|
|
CLASSIFICATION |
PROTON PUMP INHIBITORS / | |
PHYSICAL AND CHEMICAL PROPERTIES |
||
PHYSICAL STATE | white to off-white crystalline powder | |
MELTING POINT | ||
BOILING POINT | ||
SPECIFIC GRAVITY | ||
SOLUBILITY IN WATER | Soluble | |
pH | ||
VAPOR DENSITY |
|
|
AUTOIGNITION |
|
|
NFPA RATINGS |
||
REFRACTIVE INDEX |
|
|
FLASH POINT | ||
STABILITY |
Stable under ordinary conditions. |
|
APPLICATIONS |
||
Proton Pump Inhibitors (PPIs) are a group of drugs to reduce the production of
acid by blocking the enzyme (hydrogen-potassium adenosine triphosphatase) in
parietal cells that produces acid. They are used in the treatment of ulcers
caused by taking nonsteroidal anti-inflammatory drugs, Zollinger-Ellison
syndrome, and symptomatic gastroesophageal reflux disease. They are also used in
eradicating Helicobacter pylori, in combination with antibiotics (e.g.
amoxycillin, clarithromycin or metronidazole in case of
penicillin-hypersensitive patients). Another lowering-acid medicines are H2
antagonist drugs which reduce the production of acid by blocking the H2 subtype
of histamine receptors.
Commecially available PPIs include;
Omeprazole, a substituted benzimidazole, is a PPI used in the treatment of symptomatic gastroesophageal reflux disease and in combination with clarithromycin duodenal ulcer associated with Helicobacter pylori infection. It is a white to off-white crystalline powder; melts or decomposes at 155 C; very slightly soluble in water; slightly soluble in acetone, isopropanol; freely soluble in ethanol and methanol; administered orally. It is a weak base; unstable under acid conditions, but stable in alkaline media. The chemical designation is (R,S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl) methyl]sulfinyl]- 1H-benzimidazole. |
||
SALES SPECIFICATION | ||
APPEARANCE |
white to off-white crystalline powder | |
IDENTIFICATION |
Complies Test A,B,C |
|
ASSAY (HPLC) |
98.5 - 101.5% |
|
pH |
10.3 - 11.3 (0.02mg/ml solution) |
|
SOLVENT RESIDUE |
0.01% max |
|
SULFATED ASH |
0.1% max |
|
HEAVY METALS |
20ppm max |
|
LOSS ON DRYING |
0.1% max |
|
TRANSPORTATION | ||
PACKING |
|
|
HAZARD CLASS | ||
UN NO. | ||
OTHER INFORMATION | ||
Hazard Symbols: XN, Risk Phrases: 20/21/22, Safety Phrases: 36 | ||
PRICES | ||
|
|